Elevance Health (ELV) Receivables (2009 - 2026)

Elevance Health (ELV) has 18 years of Receivables data on file, last reported at $17.7 billion in Q1 2026.

• Receivables for Q1 2026 came in at $17.7 billion, up 4.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.7 billion (up 4.47% YoY), and the FY2025 annual result was $16.4 billion, up 16.77% from the prior year.
• Receivables improved to $17.7 billion in Q1 2026 per ELV's latest filing, from $16.4 billion in the prior quarter.
• Over five years, Receivables peaked at $17.7 billion in Q1 2026 and troughed at $10.3 billion in Q3 2022.
• A 5-year average of $13.9 billion and a median of $13.3 billion in 2023 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2024: Receivables surged 58.49% in 2022, then advanced 0.67% in 2024.
• A 5-year view of Receivables shows it stood at $11.4 billion in 2022, then advanced by 16.92% to $13.3 billion in 2023, then rose by 5.41% to $14.0 billion in 2024, then grew by 16.77% to $16.4 billion in 2025, then advanced by 8.01% to $17.7 billion in 2026.
• Business Quant data shows ELV's Receivables at $17.7 billion in Q1 2026, $16.4 billion in Q4 2025, and $17.2 billion in Q3 2025.